Market News & Trends
Valeant Pharmaceuticals Agrees to Acquire iNova Pharmaceuticals
Valeant Pharmaceuticals International, Inc. recently announced it has signed an agreement to acquire iNova, a private pharmaceutical group that sells and distributes a range of…
11/29/2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen in India. Under the…
Aileron Therapeutics, Roche Expand $1.1-Billion Drug Collaboration
Aileron Therapeutics recently announced that Roche will initiate a new program to expand its collaboration with Aileron to discover, develop, and commercialize Stapled Peptide drugs.…
Biocon Launches Haselmeier's Insulin Pen in India
Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen in India. Under the terms of the agreement between the two…
Gilead Sciences to Acquire Pharmasset for $11 Billion
Gilead Sciences, Inc. and Pharmasset, Inc. recently announced the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share…
Isis to Receive $14 Million for Its Excaliard Acquisition
Isis Pharmaceuticals, Inc. recently announced it will receive up to $14 million from Pfizer Inc. for its equity ownership of Excaliard Pharmaceuticals, Inc. from Pfizer's…
11/22/2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life Science Limited Partnership, has completed…
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting
Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life Science Limited Partnership, has completed a successful pre-IND meeting with the US FDA regarding…
Bend Research Signs Technology Licensing Agreement With Merck
Bend Research Inc., a leading independent drug formulation development and manufacturing company, recently announced it has entered into a licensing agreement with Merck, through a…
INNERCAP Technologies Granted Patent Application for Capsular Delivery System
INNERCAP Technologies, Inc., an international drug delivery and specialty pharmaceutical company, recently announced the grant of Canadian Patent Application No. 2,481,486 titled Multi-Phase, Multi-Compartment Capsular…
MonoSol Rx & Midatech Ltd Receive Authorization to Conduct Phase I Human Trials
MonoSol Rx, the developer of PharmFilm drug delivery technology, and its collaboration partner Midatech Ltd., a global leader and centre of excellence for the design,…
Porex Corporation Introduces POREX BioDesign Glass Fiber
Porex Corporation, a proven market leader in porous media solutions for the healthcare, industrial, and consumer markets, has recently launched an innovative line of glass…
Unilife Corporation Announces Pricing of Common Stock Offering
Unilife Corporation recently announced the pricing of its underwritten registered public offering of 8,250,000 shares of common stock at a public offering price of $4.35…
11/15/2011
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently announced they have entered into…
Accentia Biopharmaceuticals to Sell Analytica for $10 Million
Accentia Biopharmaceuticals, Inc. recently announced it has entered into a series of agreements to strengthen its financial position, improve its balance sheet, and support ongoing…
Daiichi Sankyo to License ARQ 092 From ArQule
ArQule, Inc. and Daiichi Sankyo, Co. Ltd. recently announced the execution of a license agreement for the development of a new AKT inhibitor called ARQ…
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently announced they have entered into a long-term agreement for the development and commercialization of up to…
NeuroDerm Announces Positive Phase II Results of Dermal Patch for Patients with Parkinson's
NeuroDerm, Ltd. recently announced the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR,…
Positive Phase II Results Reported for Sanofi/Regeneron Pharmaceuticals Cholesterol Drug
Sanofi and Regeneron Pharmaceuticals, Inc. recently announced positive preliminary results from the Phase II study program in which patients with elevated low-density lipoprotein cholesterol (LDL-C)…
Salix Pharmaceuticals to Acquire Oceana Therapeutics for $300 Million
Oceana Therapeutics LLC, a privately owned global company focused on commercializing best-in-class specialty therapeutics, recently announced it has entered into a definitive agreement for the…
